ADIPOQ and type 2 diabetes mellitus: Recently, it has been reported that inflammatory biomarkers including CRP failed to predict type 2 diabetes after adjustment for the traditional markers such as age, sex, BMI and waist circumference [31], [32], whereas Ong et al., have reported that adding CRP and adiponectin to the traditional markers improved predictive ability for deterioration in glycemia, especially in women [30].